Skip to main content
. 2010 Aug 23;31(10):1805–1812. doi: 10.1093/carcin/bgq168

Table III.

HRs of single SNPs and RCC recurrence

Gene SNP Allelesa Minor allelle frequency (recurrence/no recurrence) Best-fitting genetic model (All histology types)
Best-fitting genetic model (Clear cell carcinoma)
Model HR (95% CI)b P-valuec Model HR (95% CI)b P-value
Biogenesis pathway
    DROSHA rs6877842 G/C 0.13/0.14 DOM 0.52 (0.23–1.18) 0.118 DOM 0.36 (0.130.98) 0.046
rs10719 C/T 0.21/0.26 ADD 0.61 (0.34–1.10) 0.102 ADD 0.63 (0.33–1.20) 0.161
    DGCR8 rs417309 G/A 0.05/0.05 DOM 0.52 (0.17–1.65) 0.269 DOM 0.79 (0.24–2.55) 0.693
rs3757 G/A 0.17/0.24 DOM 0.61 (0.30–1.22) 0.163 DOM 0.57 (0.25–1.30) 0.182
rs1640299 G/T 0.45//0.51 DOM 0.95 (0.49–1.86) 0.889 DOM 0.86 (0.40–1.87) 0.708
    XPO5 rs11077 A/C 0.45/0.44 DOM 0.57 (0.29–1.13) 0.109 DOM 0.36 (0.160.85) 0.020
    RAN rs14035 C/T 0.28/0.29 DOM 0.55 (0.27–1.11) 0.097 DOM 0.50 (0.23–1.09) 0.080
    DICER rs3742330 A/G 0.04/0.06 DOM 0.75 (0.23–2.45) 0.640 DOM 0.52 (0.13–2.04) 0.348
rs13078 T/A 0.14/0.19 DOM 0.77 (0.39–1.55) 0.468 DOM 0.61 (0.26–1.41) 0.244
    TRBP rs784567 C/T 0.47/0.40 DOM 0.79 (0.37–1.68) 0.534 REC 1.31 (0.60–2.86) 0.493
    AGO1 rs636832 G/A 0.10/0.15 DOM 0.82 (0.32–2.11) 0.680 DOM 0.69 (0.24–1.99) 0.497
rs595961 A/G 0.16/0.22 REC 3.52 (0.88–14.02) 0.075 REC 3.65 (0.71–18.68) 0.120
    AGO2 rs4961280 C/A 0.20/0.20 REC 2.74 (0.30–24.66) 0.369 DOM 0.62 (0.27–1.47) 0.280
    GEMIN4 rs910924 C/T 0.26/0.23 DOM 1.53 (0.76–3.09) 0.234 DOM 1.27 (0.54–3.02) 0.585
rs2740348 G/C 0.16/0.15 DOM 0.88 (0.42–1.84) 0.740 DOM 1.15 (0.50–2.64) 0.744
rs7813 T/C 0.41/0.36 REC 1.69 (0.67–4.28) 0.268 ADD 1.38 (0.80–2.37) 0.246
rs910925 G/C 0.41/0.36 REC 1.69 (0.67–4.28) 0.268 ADD 1.38 (0.80–2.37) 0.246
rs3744741 C/T 0.16/0.17 DOM 0.62 (0.30–1.27) 0.190 DOM 0.67 (0.28–1.57) 0.354
rs1062923 T/C 0.16/0.15 DOM 1.09 (0.50–2.38) 0.837 DOM 0.88 (0.33–2.35) 0.801
rs4968104 T/A 0.23/0.21 DOM 1.63 (0.85–3.12) 0.144 DOM 1.30 (0.55–3.05) 0.546
    GEMIN3 rs197414 C/A 0.12/0.13 DOM 0.72 (0.30–1.71) 0.46 REC 0.70 (0.28–1.74) 0.44
rs197388 T/A 0.22/0.21 DOM 0.57 (0.28–1.15) 0.12 REC 0.43 (0.19–0.98) 0.05
rs197412 T/C 0.42/0.44 REC 0.51 (0.21–1.24) 0.137 REC 0.39 (0.14–1.08) 0.069
    HIWI rs1106042 G/A 0.05/0.07 DOM 0.52 (0.15–1.74) 0.288 DOM 0.54 (0.16–1.84) 0.325
Pre-miRNA
    mir146a rs2910164 G/C 0.23/0.27 DOM 0.47 (0.240.92) 0.029 DOM 0.42 (0.190.90) 0.026
    mir196a-2 rs11614913 C/T 0.34/0.38 DOM 0.37 (0.190.73) 0.004 DOM 0.29 (0.140.64) 0.002
    mir423 rs6505162 C/A 0.43/0.48 REC 0.39 (0.170.89) 0.026 REC 0.46 (0.19–1.13) 0.091
    mir492 rs2289030 C/G 0.06/0.08 DOM 0.79 (0.25–2.48) 0.692 DOM 0.58 (0.13–2.62) 0.476
    mir604 rs2368392 C/T 0.22/0.28 REC 0.27 (0.04–1.99) 0.197 REC 0.28 (0.04–2.16) 0.223
    mir608 rs4919510 C/G 0.29/0.22 ADD 1.88 (1.123.16) 0.017 ADD 2.21 (1.243.92) 0.007
    mir631 rs5745925 CT/— 0.11/0.08 DOM 3.93 (1.699.17) 0.002 DOM 4.62 (1.7212.40) 0.002
Pri-miRNA
    let7f-2 rs17276588 G/A 0.05/0.03 DOM 1.05 (0.32–3.43) 0.929 DOM 1.43 (0.41–4.98) 0.573
    mir26a-1 rs7372209 C/T 0.26/0.29 DOM 0.84 (0.43–1.65) 0.622 ADD 0.67 (0.33–1.37) 0.274
    mir30a rs1358379 A/G 0.06/0.03 DOM 1.36 (0.44–4.18) 0.595 DOM 1.41 (0.36–5.56) 0.620
    mir30c-1 rs16827546 C/T 0.00/0.04 N/A N/A N/A N/A N/A N/A
    mir100 rs1834306 C/T 0.40/0.49 REC 0.51 (0.21–1.24) 0.139 REC 0.53 (0.20–1.42) 0.206
    mir124-1 rs531564 C/G 0.13/0.11 DOM 1.83 (0.83–4.07) 0.136 DOM 1.95 (0.83–4.59) 0.127
    mir219-1 rs107822 G/A 0.27/0.27 DOM 1.85 (0.89–3.83) 0.097 DOM 2.18 (0.94–5.09) 0.071
rs213210 T/C 0.08/0.07 DOM 1.47 (0.60–3.59) 0.401 DOM 1.47 (0.56–3.85) 0.433
    mir373 rs12983273 C/T 0.14/0.14 DOM 1.68 (0.80–3.53) 0.174 DOM 1.23 (0.52–2.87) 0.640
rs10425222 C/A 0.06/0.05 DOM 1.84 (0.64–5.27) 0.258 DOM 2.39 (0.69–8.26) 0.168
a

Major/minor alleles.

b

Adjusted for age, sex, ethnicity, smoking status, stage, grade and treatments. P-value < 0.05 was in bold and used in the unfavorable genotype analysis.

c

Underlined P-values remained significant after false discovery rate adjustment at 0.05 level.